CMBI: Raises Target Price for Kelun-Biotech (06990.HK) to HK$645.62, Maintains "Buy" Rating

Zhitong Finance APP has learned that CMBI has issued a research report stating that it has raised the target price of Kelun-Biotech (06990.HK) by 0.5%, from HK$642.99 to HK$645.62, while maintaining a "Buy" rating.